# Safety Study of 20,000 EU of Clinical Center Reference Endotoxin in Allergic Adults With and Without Mild Asthma

> **NCT00630461** · PHASE1 · TERMINATED · sponsor: **University of North Carolina, Chapel Hill** · enrollment: 4 (actual)

## Conditions studied

- Mild Allergic Rhinitis
- Mild Allergic Rhinitis With Mild Asthma

## Interventions

- **BIOLOGICAL:** Clinical Center Reference Endotoxin

## Key facts

- **NCT ID:** NCT00630461
- **Lead sponsor:** University of North Carolina, Chapel Hill
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2008-05
- **Primary completion:** 2012-05
- **Final completion:** 2012-05
- **Target enrollment:** 4 (ACTUAL)
- **Why stopped:** Data collected under different protocol; funding exhuasted
- **Last updated:** 2012-10-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00630461

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00630461, "Safety Study of 20,000 EU of Clinical Center Reference Endotoxin in Allergic Adults With and Without Mild Asthma". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00630461. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*